Cosmo Pharmaceuticals - 股票

Cosmo Pharmaceuticals 投资回报率 2024

Cosmo Pharmaceuticals 投资回报率

0

股票代码

COPN.SW

ISIN

NL0011832936

WKN

A2AJ68

在2024年,Cosmo Pharmaceuticals的资本回报率(ROCE)为0,相较于前一年的0.06 ROCE,增长了-100%

Cosmo Pharmaceuticals Aktienanalyse

Cosmo Pharmaceuticals在做什么?

Cosmo Pharmaceuticals NV is an international pharmaceutical company based in Dublin, Ireland. The company focuses on developing innovative drugs for various diseases, including gastroenterology, oncology, and infectious diseases. The history of Cosmo Pharmaceuticals dates back to 1997 when it was founded by Dr. Mauro Ajani in Italy. Since then, the company has undergone impressive development and is now listed on the SIX Swiss Exchange. In 2020, the company moved from Italy to Ireland to strengthen its international presence. Cosmo Pharmaceuticals' business model is based on creating patented innovations and technologies in drug development. The company works closely with other companies and research institutions to introduce a wide range of products that benefit both patients and healthcare providers. The main source of income for Cosmo Pharmaceuticals is the licenses they grant for their products, as well as the manufacturing and sale of their own products. Cosmo Pharmaceuticals operates three main business areas: Human, Veterinary, and Proprietary. The Human division specializes in the development of drugs for humans. The company's products are available worldwide, including in the United States, Europe, Japan, and China. In the field of gastroenterology, Cosmo Pharmaceuticals is one of the leading companies on the market and has developed several products to treat gastrointestinal problems and other gastrointestinal diseases. The Veterinary division of Cosmo Pharmaceuticals specializes in the development of animal medicines. The company works with veterinarians and pet owners to bring products to market that help animals stay healthy or recover. Cosmo Pharmaceuticals offers several products tailored to the specific needs of animals, including Ballistol Animal, used for skin and fur care, and Otilonium Bromide, used for digestive disorders in horses. The Proprietary division is the third major business area of Cosmo Pharmaceuticals. This is a segment that manufactures its own products and sells them directly to patients or institutions. The company's products include Eleview, used in endoscopy to improve visibility of the gastrointestinal mucosa. Cosmo Pharmaceuticals is an innovative company focused on the development of drugs that can help improve patients' lives. The company collaborates closely with other companies and research institutions to leverage the latest technologies and developments in the industry. With its broad portfolio of products in the field of gastroenterology, oncology, and infectious diseases, the company has a strong presence in the industry and actively advocates for more people to have access to the best medical treatments. Cosmo Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

投资回报率的详细信息

Cosmo Pharmaceuticals的资本投入回报率(ROCE)解读

Cosmo Pharmaceuticals的资本投入回报率(ROCE)是一个财务指标,用来衡量公司对投入资本的盈利能力和效率。它是通过将税前利息和税款前的利润(EBIT)除以投入的资本来计算的。较高的ROCE表示公司能有效地利用其资本来盈利。

年度对比

Cosmo Pharmaceuticals的ROCE年度分析提供了对其资本投入利用效率的有价值的见解。ROCE的增加可能预示着改善的盈利能力和运营效率,而下降可能在资本使用或业务运作中指出潜在的问题。

对投资的影响

Cosmo Pharmaceuticals的ROCE是投资者和分析师在评估公司效率和盈利能力时的关键因素。较高的ROCE可能会使该公司成为一个吸引人的投资,因为这通常表明该公司能获得充足的资本投入收益。

解读ROCE的波动

Cosmo Pharmaceuticals的ROCE变动由EBIT或投入资本的变动引起。这些波动为公司的运营效率、财务表现和策略性财务管理提供了见解,并帮助投资者做出明智的决策。

关于Cosmo Pharmaceuticals股票的常见问题

Cosmo Pharmaceuticals今年的ROCE(投入资本回报率)有多高?

Cosmo Pharmaceuticals今年的ROCE为0 undefined。

Cosmo Pharmaceuticals的ROCE(资本运用回报率)与去年相比有何变化?

相比去年,Cosmo Pharmaceuticals的ROCE已经下降了-100%。

对Cosmo Pharmaceuticals的投资者来说,高ROCE(资本运营回报率)意味着什么?

高ROCE(资本运用回报率)意味着Cosmo Pharmaceuticals有效地使用了他的资本并且可以实现更高的投入资本回报。这对投资者可能具有吸引力。

对Cosmo Pharmaceuticals的投资者来说,较低的ROCE(投入资本回报率)意味着什么?

一个较低的ROCE(投入资本回报率)可能表明Cosmo Pharmaceuticals在利用其资本方面效率较低,可能难以在其投入的资本上获得适当的回报。这对投资者来说可能存在不确定性或缺乏吸引力。

Cosmo Pharmaceuticals的ROCE增加会对公司产生什么影响?

ROCE的增加Cosmo Pharmaceuticals可能是公司效率提高的指标,并显示出它相对于其投资获得了更高的利润。

Cosmo Pharmaceuticals的ROCE降低会对公司产生什么影响?

ROCE的降低Cosmo Pharmaceuticals可能是公司效率下降的指标,并显示它相对于其投资获得了较低的收益。

有哪些因素可能影响Cosmo Pharmaceuticals的ROCE?

影响Cosmo Pharmaceuticals的ROCE的一些因素包括资产管理效率、投资盈利能力、成本效率和市场情况。

为什么Cosmo Pharmaceuticals的ROCE对投资者如此重要?

Cosmo Pharmaceuticals的ROCE对投资者很重要,因为它是衡量公司效率的指标,显示出公司相对于其投资的成功程度。高ROCE可能表明公司的财务表现强劲。

Cosmo Pharmaceuticals可以采取哪些战略措施来提高ROCE?

为了提高Cosmo Pharmaceuticals的ROCE,可以采取包括提高资产效率、优化投资、节约成本和开发新的收入来源等措施。公司进行全面审查其业务活动以确定最佳策略措施以提高ROCE是非常重要的。

Cosmo Pharmaceuticals支付多少股息?

在过去的12个月中,Cosmo Pharmaceuticals支付了1.05 EUR 的股息。这相当于大约1.43 %的股息收益率。在未来的12个月内,Cosmo Pharmaceuticals预计将支付1.05 EUR的股息。

Cosmo Pharmaceuticals的股息收益率有多高?

Cosmo Pharmaceuticals当前的股息收益率为1.43 %。

Cosmo Pharmaceuticals什么时候支付股息?

Cosmo Pharmaceuticals按季度支付股息。这些股息将在, , , 月份分发。

Cosmo Pharmaceuticals的股息有多安全?

Cosmo Pharmaceuticals 在过去8年里每年都支付了股息。

Cosmo Pharmaceuticals的股息有多高?

预计未来12个月的股息将达到1.05 EUR。这相当于1.43 %的股息收益率。

Cosmo Pharmaceuticals位于哪个行业?

Cosmo Pharmaceuticals 被分配到“健康”板块。

Wann musste ich die Aktien von Cosmo Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

要获得Cosmo Pharmaceuticals在支付的2.17 EUR的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Cosmo Pharmaceuticals最后一次支付股息是什么时候?

上一次股息发放日期为。

Cosmo Pharmaceuticals在2023年的股息是多少?

在2023年,Cosmo Pharmaceuticals 分配了0.95 EUR作为股息。

Cosmo Pharmaceuticals 的股息是以哪种货币支付的?

Cosmo Pharmaceuticals的股息将以EUR的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von Cosmo Pharmaceuticals

我们对Cosmo Pharmaceuticals 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Cosmo Pharmaceuticals 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: